As President and Founder of Irvine Pharmaceutical Services, Inc. has more than 30 years of research experience in analytical chemistry and biochemistry, and management of analytical and quality control laboratories in the pharmaceutical and biotechnology industries. Additionally, Dr. Kazeminy has extensive and proficient knowledge of FDA regulations. He was introduced to ARM during 2007 as an invaluable adviser for chemical, manufacturing, and control (CMC) of novel therapeutics for HIBM.
Dr. Kazeminy has a Ph.D. in Pharmaceutical Science and Biochemistry and has completed a postdoctorate at the USC Medical School, Department of Pharmacology. Dr. Kazeminy has taught at USC and conducted research at the University of California, Irvine.
Dr. Kazeminy is active in national and local organizations and has held various leadership roles, including serving as a selected reviewer for the United States Pharmacopeia; a prominent member of the University of Irvine Chief Executive Roundtable; the Chairperson of the FDA Grass Roots, Pacific Region Importing Community Steering Committee; the President of AOAC, International Southern California Section; the Executive Chairperson of the Southern California Pharmaceutical Discussion Group; the President of ACS, Southern California Section; the Chairperson of the Pharmaceutical section of ACIL; the President of ASIPS; and a Board Member of the Analytical Accreditation of AIHA. He has made many contributions towards advancing the pharmaceutical sciences, and his efforts have been influential in shaping and reforming current industry standards.